Ding, Eric PhD
Faculty at
Harvard University (HU), Cambridge MA
Senior researcher
with 173 publications
in the last 21 years
ORCID:
0000-0002-5881-8097
Public Health, Environmental and Occupational Health
Dr. Eric Feigl-Ding is an epidemiologist and health economist and a Senior Fellow at the Federation of American Scientists in Washington DC. He was previously a faculty and researcher at Harvard Medical School and Harvard Chan School of Public Health between 2004-2020, and an epidemiologist at the Brigham and Women's Hospital. In January 2020, he was recognized in the media as one of the first to alert the public on the pandemic risk of COVID-19. He focuses his efforts on analyzing COVID-19 trends, stop COVID-19 misinformation, advocate for public health, and improve health policy. Dr. Feigl-Ding’s work focuses on the intersection of public health and public policy. He also currently works on social-network based behavioral interventions for prevention, drug safety, diabetes/obesity prevention, and public health programs in the US and globally. He has further expertise in designing and conducting randomized trials, systematic reviews, public health programs, and improving health policy. He was noted in his role as a whistleblower and leader of a key two-year-long investigation into the controversial drug safety and risk data of Vioxx®, Celebrex®, and Bextra® that drew FDA and national attention. Highlighted and express-published in JAMA, as corresponding joint-first author, he was also recognized for his role in the New York Times, and in the book Poison Pills: The Untold Story of the Vioxx Drug Scandal. A childhood survivor and cancer prevention advocate, he was called one of the ‘Facebook philanthropists‘, founding the 6 million member online Campaign for Cancer Prevention, featured in Newsweek magazine in 2007. In total online reach, he previously directed disease prevention advocacy platforms with over 10 million members on Facebook Causes. He led the first ever direct-to-science online crowdfunding initiative, fundraising over $500,000 (median public donation $15) for medical research, led a partnership with Brigham and Women's Hospital, and featured in the New York Times in 2009. In the aftermath of the Flint Water Crisis, he founded the first geo-social network and public alert system for drinking water toxic contamination, as featured in WIRED. He established the Toxin Alert Drinking Water Database with 500,000-locations nationwide for informing the public about water hazards in communities. For his work, he was awarded the 2017 Mark V. Anderson Leadership Award from Sigma Chi Foundation. Previously, during the 2014 Ebola pandemic, he led a team to co-develop one of the first mobile contact-tracing applications for infectious disease outbreaks. The project was shelved after lack of interest in pandemic preparedness technology. His early contact-tracing app's contributions lived on to inform the later designs of contact tracing apps developed during the COVID-19 outbreak. He has published in leading journals, including the New England Journal of Medicine, Journal of the American Medical Association, The Lancet, and more. His 150+ publications have received 85,000 citations (H-Index 81). As a Web of Science Highly Cited Researcher, he was ranked in 2018 as among the Top 1% of all scientists worldwide, and named among the 186 top cited scholars across Harvard University. Altogether, his competitively awarded projects as PI/Director have received over $10 million in funding. A World Economic Forum Global Shaper, he has chaired committees for the Health Directorate of the European Commission, advised the World Health Organization, Denmark Ministry of Health, and served as a member of the Global Burden of Disease Project. He also advised and successfully convinced the C-suite leaders of a major Fortune 100 food/beverage company to adopt the WHO health recommendations for added sugars. He has also advised many governors, state legislators, members of Congress, and other world leaders. Dr. Feigl-Ding graduated from The Johns Hopkins University with Honors in Public Health and Phi Beta Kappa. He then completed his dua
show More
Preview
Evolution over the last 10 years of activity
Aggregated career metrics
173
Total documents
75.52
Normalized Impact
83
Highly Cited Papers (10%)
36.42
International Collab. (%)
Most cited publications
Main coauthors
Following you can review Eric's accomplishments in each of the dimensions.
The perfect present for a young Researcher!
Let's do it!
Dimensions One by One
Spanning 73 diverse indicators, the dimensions considered capture a comprehensive spectrum of academic
attributes.
Each dimension includes a set of indicators and has a especific weight on the One Index.
More information here...
Activity
949
/1000
Reflects an author's research output.
Impact
997
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
Excellence
989
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
Leadership
613
/1000
Reflects an author's efforts and commitment in leading research initiatives.
Cooperation
893
/1000
Reflects a researcher's ability to navigate and thrive in varied academic and research environments, highlighting adaptability, resourcefulness, and the capacity to build and maintain collaborative relationships across the spectrum of their career.
Openness
961
/1000
Reflects an author's commitment to making their research freely accessible and open to the public.
Community Support
0
/1000
Reflects an author's contributions to the academic community beyond their own research.
Community Recognition
0
/1000
Reflects the academic community's acknowledgment and appreciation of an author's contributions.
Transference
173
/1000
Reflects an author's commitment to making their research a practical application and real-world impact of an author's research.
Fundraising
0
/1000
Reflects an author's ability in securing project funding from major global entities, showcasing your ability to drive research initiatives forward.
All indicators
Performance
Activity
Reflects an author's research output.
| Documents | 173 | Count of all document types. |
|---|---|---|
| Docs/Year | 8.24 | Average of documents published by author per year. |
| Citable docs | 150 | Count of journal articles, proceeding papers and reviews. |
| Journal Articles | 119 | Documents published as articles in scientific journals usually peer-reviewed. |
| Conferences | 0 | Original article reporting data presented at a conference or symposium. |
| Reviews | 31 | Review papers authored by the researcher. |
| Patents | 0 | Intellectual property that gives its owner the legal right to exclude others from making, using, or selling an invention for a limited period of time in exchange for publishing an enabling disclosure of the invention. |
| Theses | 0 | Document submitted in support of candidature for an academic degree or professional qualification presenting the author's research and findings |
| Books | 0 | A whole monograph or the entire book. |
| Book Chapters | 0 | Complete chapter in a book or book series volume where the item is identified as a chapter by a heading or section indicator. |
| Datasets | 2 | Number of dataset where the author have contributed to the creation. |
| Editorials | 1 | Papers where the author contributed editorial content. |
| Reports | 0 | Research reports or white papers authored. |
| Grants | 0 | Research projects funded through external grants awarded to the author. |
| Pre-Prints | 4 | Number of publications freely available in pre-print format. |
| Clinical Trials | N/A | Number of clinical trials where the author has participated. |
| Other types | 0 | Other type of documents. |
Impact
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
| Citations | 117218 | Total number of citations to all the publications attributed to the author (all types). |
|---|---|---|
| Self Citations | 271 | Citations where the author references their own previous work. |
| Self Citation Rate | 0.231 | Percentage of self-citations in the author's total citation count. |
| Non Self Citation Rate | 99.769 | Percentage of citations received from sources that are not self-citations. |
| Hot Citations | 3741 | Total number of citations recieved in the last 6 months. |
| Citations/Document | 677.56 | Average of citations recieved per document. |
| % Not Cited | 0.0 | Percentage of documents with no citations recieved. |
| Relative Citation Index | 75.517 | Item oriented indicator consisting of the quotient between the number of citations to a given work and the average number of citations to works of the same type, year and discipline. An author's RCI corresponds to the average of the values of his/her publications. |
| Journal Relative Citation Index | 12.266 | Item oriented indicator consisting of the quotient between the number of citations to a given work and the average number of citations to works of the same type, year and journal. An author's RCI corresponds to the average of the values of his/her publications. |
| H Index | 77 | Maximum value of h such that the given author has published at least h papers that have each been cited at least h times. |
| G Index | 147 | Maximum value of g such that the given author has published at least g papers that have each been cited at least g^2 times. |
| i10 Index | 113 | Number of documents with at least 10 citations recieved. |
Excellence
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
| Citation Score | 0.751 | Ratio between 0 and 1 being 0 corresponding to the citation percentile being 0 the 0th and 1 the 100th. |
|---|---|---|
| Citation Normalized Percentile | 0.727 | Citation percentile normalized to 1 (0 worst, 1 best) of the position in citations rankin within the field. Provided by OpenAlex. |
| Higly Cited Papers (top 10%) | 83 | Count of publications falling on or above the 90th citation percentile in the cohort of publications of the same type, year and discipline. |
| Relative Higly Cited Papers | 4.798 | Quotient between the real number of Highly Cited Papers (HCP) and expected number of HCP's that is the 10% of total documents. |
| Outstanding Papers (top 1%) | 52 | Count of publications falling on or above the 99th citation percentile in the cohort of publications of the same type, year and discipline. |
| Relative Outstanding Papers | 30.058 | Quotient between the real number of Outstanding Papers (OP) and expected number of OP's that is the 1% of total documents. |
| Outstanding Papers (top 0.1%) | 31 | Count of publications falling on or above the 99.9th citation percentile in the cohort of publications of the same type, year and discipline. |
| Hot Papers | 48 | Using only the citations recieved in the last 6 months: documents falling on or above the 99th citation percentile in the cohort of publications of the same type, year and discipline. |
Interaction within community
Leadership
Reflects an author's efforts and commitment in leading research initiatives.
| Docs Leadership | 49 | Number of documents lead by the author. |
|---|---|---|
| % Leadership | 28.32 | Percentage of documents lead by the author. |
| Docs International Leadership | 13 | Number of documents in international collaboration lead by the author. |
| % International Leadership | 7.51 | Percentage of documents in international collaboration lead by the author. |
| Principal Investigator | 0 | Number of times where the author served as the lead researcher in a project. |
| Associations Founded | 0 | Number of associations founded by the author. |
| Societies Founded | 0 | Number of scientific or professional societies established by the author. |
| Foundations Founded | 0 | Number of research-related foundations established by the author. |
| Councils | 0 | Number of councils founded by author. |
Cooperation
Reflects a researcher's ability to navigate and thrive in varied academic and research environments, highlighting adaptability, resourcefulness, and the capacity to build and maintain collaborative relationships across the spectrum of their career.
| Authors/Paper | 164.5 | Average number of authors per document. |
|---|---|---|
| % Highly Authored Papers | 32.37 | Percentage of documents with 25 or more authors. |
| Countries/Paper | 6.95 | Average number of different countries in the author's affiliation line per document. |
| Docs International Collaboration | 63 | Number of documents reporting two or more different countries in the author's affiliation line. |
| % International Collaboration | 36.42 | Percentage of documents reporting two or more diffetent countries in the author's affiliation line. |
Community Support
Reflects an author's contributions to the academic community beyond their own research.
| Peer Review Counts | 0 | Number of times the author peer-reviewed publications. |
|---|---|---|
| Society Membership | 0 | Number of societies of wich the author is a member. |
| Society Memberships | 0 | Memberships held by the author in scientific or professional societies. |
| Editorial Board Memberships | 0 | Number of journals where the author has been member of editorial board. |
| Panelists | 0 | Number of times the author have been a panelist in the European Research Council (ERC) calls. |
Community Recognition
Reflects the academic community's acknowledgment and appreciation of an author's contributions.
| Distinctions | 0 | Number of times the author have recieved a distinction for its career. |
|---|---|---|
| Invitations | 0 | Number of times the author has been invited to talks, professorships, expositions or demonstrations. |
| Talks | 0 | Number of times the author has been invited to talks. |
| Professorships | 0 | Number of times the author has been invited to professorhips. |
| Commissioned Reports | 0 | Commissioned reports done by the author. |
Interaction with society
Openness
Reflects an author's commitment to making their research freely accessible and open to the public.
| Open Access Documents | 120 | Number of documents in Open Access mode. |
|---|---|---|
| % Open Access Documents | 69.36 | Percentage of documents in Open Access mode. |
| Open Access Gold | 26 | Number of documents published in an OA journal that is indexed by the DOAJ. |
| Open Access Green | 22 | Toll-access on the publisher landing page, but there is a free copy in an OA repository. |
| Open Access Hybrid | 31 | Free under an open license in a toll-access journal. |
| Open Access Bronze | 40 | Free to read on the publisher landing page, but without any identifiable license. |
| Open Access Closed | 53 | Non Open Access documents. |
Transference
Reflects an author's commitment to making their research a practical application and real-world impact of an author's research.
| Patents | 0 | Intellectual property that gives its owner the legal right to exclude others from making, using, or selling an invention for a limited period of time in exchange for publishing an enabling disclosure of the invention. |
|---|---|---|
| Advisory Boards | 0 | Number of advisory boards of which the author is member. |
| Companies | 0 | Number of companies created or founded by the author. |
Fundraising
Reflects an author's ability in securing project funding from major global entities, showcasing your ability to drive research initiatives forward.
| Funding Counts | 0 | Number of activities reported as funding recieved. |
|---|---|---|
| ERC Grantees | 0 | Researchers awarded grants from the European Research Council. |